Moreover, it was demonstrated that 3 days of ketamine treatment mitigated the depression-induced excessive expression of nNOS and up-regulated the expression of CAPON and Dexras1, and restored the efficacy balance between total nNOS and the nNOS–CAPON–Dexras1 complex. This evidence concerns the gene RASD1 and depressive symptom measurement.